Form 4: OptimizeRx Corp Executive Exercises Stock Options, Disposes of Shares for Tax Obligations
SEC Form 4 Filing
Marion Odence-Ford, General Counsel and CCO of OptimizeRx Corp, exercised stock options and disposed of shares to cover tax obligations on February 11, 2025.
Summary
- On February 11, 2025, Marion Odence-Ford, the General Counsel and CCO of OptimizeRx Corp, exercised restricted stock units converting into 4,000 shares of common stock.
- Simultaneously, 1,386 shares were disposed of at a price of $5.6 to satisfy tax withholding obligations.
- Following these transactions, Odence-Ford directly owns 71,252 shares of common stock and 12,000 restricted stock units.
Sentiment
Score: 5
Explanation: The document reflects a neutral sentiment as it reports standard insider trading activity related to stock compensation and tax obligations.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency in stock transactions by company insiders. This filing indicates routine activity related to stock-based compensation.
Stakeholder Impact
- The transaction has a minimal impact on shareholders as it involves a small number of shares and is related to executive compensation.
Key Dates
| Date | Description |
|---|---|
| 02/11/2021 | Reporting person was granted 20,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| 02/11/2025 | Date of transaction: Exercise of restricted stock units and disposition of shares for tax obligations. |
| 02/13/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.